United Therapeutics CEO Martine Rothblatt reports $4.99 million stock disposal
UTHR•Martine Rothblatt reported exercising options for 9,500 United Therapeutics shares and selling 8,994 shares held by a trust on Oct. 1, 2026. The trust’s holdings fell to 324,443 shares after the sales.
1. Option exercise and sale
United Therapeutics Chairperson and CEO Martine A. Rothblatt reported exercising options for 9,500 shares on Oct. 1, 2026, at $117.76 per share. A trust held the acquired shares indirectly. The same trust sold 8,994 shares in multiple trades at prices ranging from $560.05 to $584.6622, leaving it with 324,443 shares.
2. Other reported holdings
Rothblatt also reported 40,513 shares held directly, along with additional indirect holdings through family trusts.
